Biodesix Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Biodesix
BDSX Stock  USD 9.57  0.76  7.36%   
Biodesix's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Biodesix's valuation are provided below:
Gross Profit
64 M
Profit Margin
(0.49)
Market Capitalization
88.6 M
Enterprise Value Revenue
1.7038
Revenue
80.2 M
We have found one hundred twenty available fundamental signals for Biodesix, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Biodesix prevailing market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road.

Biodesix Total Revenue

47.72 Million

Check Biodesix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biodesix's main balance sheet or income statement drivers, such as Interest Income of 25.9 K, Depreciation And Amortization of 4.3 M or Interest Expense of 6.9 M, as well as many indicators such as Price To Sales Ratio of 3.04, Dividend Yield of 0.0 or PTB Ratio of 5.59. Biodesix financial statements analysis is a perfect complement when working with Biodesix Valuation or Volatility modules.
  
Build AI portfolio with Biodesix Stock
Check out the analysis of Biodesix Correlation against competitors.
For more information on how to buy Biodesix Stock please use our How to Invest in Biodesix guide.

Biodesix Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets89.1 M111.8 M63.6 M
Slightly volatile
Short and Long Term Debt Total39.5 M71.3 M32.2 M
Slightly volatile
Other Current Liabilities16.2 M12.3 M9.2 M
Slightly volatile
Total Current Liabilities24.9 M16.5 M13.9 M
Slightly volatile
Other Liabilities19.8 M17.3 M23.8 M
Slightly volatile
Property Plant And Equipment Net35.7 M34 M9.4 M
Slightly volatile
Current Deferred Revenue1 M610.2 K865.3 K
Slightly volatile
Accounts Payable2.3 M2 M1.8 M
Slightly volatile
Cash31.7 M30.2 M18.3 M
Slightly volatile
Non Current Assets Total44.4 M66.4 M36.8 M
Slightly volatile
Non Currrent Assets Other8.8 M8.3 M2.5 M
Slightly volatile
Other Assets7.2 M6.8 M2.2 M
Slightly volatile
Long Term Debt26.6 M41.9 M24.9 M
Slightly volatile
Cash And Short Term Investments31.7 M30.2 M18.3 M
Slightly volatile
Net Receivables7.5 M9.9 M4.7 M
Slightly volatile
Good Will15.3 M17.3 M12.7 M
Slightly volatile
Common Stock Total Equity32.6 K31.1 K12.3 K
Slightly volatile
Common Stock Shares Outstanding7.5 M5.8 M5.3 M
Pretty Stable
Liabilities And Stockholders Equity89.1 M111.8 M63.6 M
Slightly volatile
Non Current Liabilities Total83.2 M55.8 M160.5 M
Slightly volatile
Inventory1.9 M1.6 M1.2 M
Slightly volatile
Other Current Assets4 M5.3 M2.7 M
Slightly volatile
Other Stockholder Equity302.8 M555.7 M167.5 M
Slightly volatile
Total Liabilities101.3 M68.7 M173.7 M
Slightly volatile
Property Plant And Equipment Gross46.8 M44.5 M11.5 M
Slightly volatile
Total Current Assets44.8 M45.4 M26.7 M
Slightly volatile
Capital Stock175.1 K166.8 K42.9 K
Slightly volatile
Non Current Liabilities Other696.8 K733.5 K19.3 M
Slightly volatile
Intangible Assets9.2 M5.3 M13.5 M
Slightly volatile
Common Stock175.1 K166.8 K42.9 K
Slightly volatile
Property Plant Equipment10.7 M10.1 M4.1 M
Slightly volatile
Short and Long Term Debt18 K18.9 K7.9 M
Slightly volatile
Short Term Debt632.7 K666 K8.1 M
Slightly volatile
Deferred Long Term Liabilities523.2 K588.6 K642.5 K
Slightly volatile

Biodesix Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Interest Income25.9 K16.2 K23.7 K
Pretty Stable
Depreciation And Amortization4.3 M6.3 M3.1 M
Slightly volatile
Interest Expense6.9 M9.5 M4.9 M
Slightly volatile
Selling General Administrative55.2 M92.5 M41.6 M
Slightly volatile
Selling And Marketing Expenses44.7 M70.7 M38.2 M
Slightly volatile
Total Revenue47.7 M82 M35.1 M
Slightly volatile
Gross Profit67.3 M64.1 M26.9 M
Slightly volatile
Other Operating Expenses84.7 M121.7 M61.9 M
Slightly volatile
Research Development11.8 M11 M9.6 M
Slightly volatile
Cost Of Revenue16.6 M17.9 M10.3 M
Slightly volatile
Total Operating Expenses68 M103.8 M51.6 M
Slightly volatile
Reconciled Depreciation4.4 M6.3 M3.1 M
Slightly volatile
Income Tax Expense5.1 M6.1 M2.7 M
Slightly volatile

Biodesix Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation4.2 M7.6 M2.3 M
Slightly volatile
Begin Period Cash Flow28.5 M30.3 M16.7 M
Slightly volatile
Depreciation4.3 M6.3 M3.1 M
Slightly volatile
Other Non Cash Items5.6 M3.5 M6.4 M
Very volatile
Capital Expenditures5.7 M3.7 M3 M
Slightly volatile
Issuance Of Capital Stock43.9 M64 M26.8 M
Slightly volatile
Total Cash From Financing Activities41.6 M59.9 M30.5 M
Slightly volatile
End Period Cash Flow31.8 M30.3 M18.4 M
Slightly volatile
Change To Netincome22.9 M21.8 M10.7 M
Slightly volatile
Sale Purchase Of Stock536.5 K718.8 K400.8 K
Slightly volatile
Dividends Paid534 K739.5 K419.9 K
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio3.043.240.4044
Very volatile
Days Sales Outstanding64.2850.6346.7281
Slightly volatile
Stock Based Compensation To Revenue0.06220.08380.0439
Slightly volatile
Capex To Depreciation0.890.530.7068
Slightly volatile
EV To Sales3.593.7840.9742
Very volatile
Inventory Turnover6.768.367.3797
Slightly volatile
Days Of Inventory On Hand49.3645.1750.9967
Slightly volatile
Payables Turnover5.636.395.9453
Pretty Stable
Sales General And Administrative To Revenue1.01.121.2257
Slightly volatile
Research And Ddevelopement To Revenue0.310.150.3321
Slightly volatile
Capex To Revenue0.03870.04080.0651
Slightly volatile
Cash Per Share3.463.646.7642
Pretty Stable
Days Payables Outstanding82.0759.1473.5664
Pretty Stable
Income Quality0.571.020.7042
Pretty Stable
Intangibles To Total Assets0.420.250.5284
Slightly volatile
Current Ratio1.512.482.0581
Pretty Stable
Receivables Turnover6.357.469.162
Slightly volatile
Capex Per Share0.430.450.894
Slightly volatile
Revenue Per Share12.149.914.7944
Very volatile
Interest Debt Per Share9.749.7515.3881
Slightly volatile
Debt To Assets0.540.730.5535
Pretty Stable
Operating Cycle48.150.6388.902
Slightly volatile
Days Of Payables Outstanding82.0759.1473.5664
Pretty Stable
Ebt Per Ebit0.971.121.1469
Pretty Stable
Quick Ratio1.462.481.9523
Very volatile
Cash Ratio1.041.651.318
Very volatile
Days Of Inventory Outstanding49.3645.1750.9967
Slightly volatile
Days Of Sales Outstanding64.2850.6346.7281
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.970.961.0971
Pretty Stable
Fixed Asset Turnover2.632.7710.8966
Slightly volatile
Debt Ratio0.540.730.5535
Pretty Stable
Price Sales Ratio3.043.240.4044
Very volatile
Asset Turnover0.440.660.5371
Pretty Stable
Gross Profit Margin0.530.70.7144
Slightly volatile

Biodesix Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap272 M306 M334 M
Slightly volatile
Enterprise Value285.7 M321.5 M350.9 M
Slightly volatile

Biodesix Fundamental Market Drivers

Biodesix Upcoming Events

4th of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Biodesix Financial Statements

Biodesix investors use historical fundamental indicators, such as Biodesix's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Biodesix. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue610.2 K1 M
Total Revenue82 M47.7 M
Cost Of Revenue17.9 M16.6 M
Stock Based Compensation To Revenue 0.08  0.06 
Sales General And Administrative To Revenue 1.12  1.00 
Research And Ddevelopement To Revenue 0.15  0.31 
Capex To Revenue 0.04  0.04 
Revenue Per Share 9.90  12.14 
Ebit Per Revenue(0.44)(0.46)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
WDWalker Dunlop
GMGeneral Motors
GMGeneral Motors

Additional Tools for Biodesix Stock Analysis

When running Biodesix's price analysis, check to measure Biodesix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biodesix is operating at the current time. Most of Biodesix's value examination focuses on studying past and present price action to predict the probability of Biodesix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biodesix's price. Additionally, you may evaluate how the addition of Biodesix to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY